Germany· DE-A57-e3fc654558d6fecd
Desveneurax
A desvenlafaxine product containing desvenlafaxine, registered in Germany by Neuraxpharm Arzneimittel Gmbh. The same ATC class is registered in 5 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Desvenlafaxine is registered in 5 of 19 countries.
Countries holding a registration under ATC N06AX23 (desvenlafaxine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 3 of them publish a price we can compare per daily dose
Desvenlafaxine · ATC N06AX23
5 / 19 countries
- Canada
- Germany
- Spainprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of desvenlafaxine costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.41 in Spain to $0.82 in Switzerland — a ×2.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Desvenlafaxine · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.82
- ES Spain$0.41
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Desvenlafaxine
- Manufacturer
- Neuraxpharm Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- N06AX23
- ATC class
- Desvenlafaxine
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
242 interactions on record for desvenlafaxine.
Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Desvenlafaxine · interactions on record
242 records
- 25 severe
- 196 moderate
- 1 minor
- 20 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Desvenlafaxine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesdesvenlafaxineDIRECT RX
- CanadaAG-DESVENLAFAXINEANGITA PHARMA INC.
- SpainDESVENLAFAXINA ALTER 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGLaboratorios Alter S.A.
- SwitzerlandDesveneurax
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Desveneurax
- Cyprus · Desvenlafaxine Adelco
- Spain · Desvenlafaxina Alter, Desvenlafaxina Cinfa
- Greece · Desvenlafaxine Adelco
- Italy · Faxilex
- Malta · Desvenlafaxine Alembic, Desvenlafaxine Waymade
- Portugal · Fasilex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7583d8b-127a-4c00-968c-5fb5ee70d795 GET /v1/drugs/b7583d8b-127a-4c00-968c-5fb5ee70d795?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Desvenlafaxine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about desvenlafaxine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.